1
|
Shan Z, Yang G, Xiang W, Pei-Jun W and Bin
Z: Effects of resveratrol on oral squamous cell carcinoma (OSCC)
cells in vitro. J Cancer Res Clin Oncol. 140:371–374. 2014.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Lu L, Xue X, Lan J, Gao Y, Xiong Z, Zhang
H, Jiang W, Song W and Zhi Q: MicroRNA-29a upregulates MMP2 in oral
squamous cell carcinoma to promote cancer invasion and
anti-apoptosis. Biomed Pharmacother. 68:13–19. 2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Xu R, Zeng G, Gao J, Ren Y, Zhang Z, Zhang
Q, Zhao J, Tao H and Li D: MiR-138 suppresses the proliferation of
oral squamous cell carcinoma cells by targeting Yes-associated
protein 1. Oncol Rep. 34:2171–2178. 2015. View Article : Google Scholar : PubMed/NCBI
|
4
|
Tan DS, Wang W, Leong HS, Sew PH, Lau DP,
Chong FT, Krisna SS, Lim TK and Iyer NG: Tongue carcinoma
infrequently harbor common actionable genetic alterations. BMC
Cancer. 14:6792014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Shi Z and Stack MS: Molecules of cell
adhesion and extracellular matrix proteolysis in oral squamous cell
carcinoma. Histol Histopathol. 25:917–932. 2010.PubMed/NCBI
|
6
|
Zhu J, Shi H, Liu H, Wang X and Li F: Long
non-coding RNA TUG1 promotes cervical cancer progression by
regulating the miR-138-5p-SIRT1 axis. Oncotarget. 8:65253–65264.
2017.PubMed/NCBI
|
7
|
Zhang Y, Dai Q, Zeng F and Liu H: MALAT1
promotes the proliferation and metastasis of osteosarcoma cells by
activating the Rac1/JNK pathway via targeting MiR-509. Oncol Res.
Apr 27–2018.(Epub ahead of print). View Article : Google Scholar
|
8
|
Zhang JJ, Wang DD, Du CX and Wang Y: Long
noncoding RNA ANRIL promotes cervical cancer development by acting
as a sponge of miR-186. Oncol Res. May 22–2017.(Epub ahead of
print). View Article : Google Scholar
|
9
|
Wang S, Hui Y, Li X and Jia Q: Silencing
of lncRNA-CCDC26 restrains the growth and migration of glioma cells
in vitro and in vivo via targeting miR-203. Oncol Res. Jun
9–2017.(Epub ahead of print). View Article : Google Scholar
|
10
|
Zhu G, Wang S, Chen J, Wang Z, Liang X,
Wang X, Jiang J, Lang J and Li L: Long noncoding RNA HAS2-AS1
mediates hypoxia-induced invasiveness of oral squamous cell
carcinoma. Mol Carcinog. 56:2210–2222. 2017. View Article : Google Scholar : PubMed/NCBI
|
11
|
Fang Z, Zhao J, Xie W, Sun Q, Wang H and
Qiao B: LncRNA UCA1 promotes proliferation and cisplatin resistance
of oral squamous cell carcinoma by sunppressing miR-184 expression.
Cancer Med. 6:2897–2908. 2017. View Article : Google Scholar : PubMed/NCBI
|
12
|
Yan G, Wang X, Yang M, Lu L and Zhou Q:
Long non-coding RNA TUG1 promotes progression of oral squamous cell
carcinoma through upregulating FMNL2 by sponging miR-219. Am J
Cancer Res. 7:1899–1912. 2017.PubMed/NCBI
|
13
|
Liu Z, Wu C, Xie N and Wang P: Long
non-coding RNA MEG3 inhibits the proliferation and metastasis of
oral squamous cell carcinoma by regulating the WNT/β-catenin
signaling pathway. Oncol Lett. 14:4053–4058. 2017. View Article : Google Scholar : PubMed/NCBI
|
14
|
Li S, Yang J, Xia Y, Fan Q and Yang KP:
Long noncoding RNA NEAT1 promotes proliferation and invasion via
targeting miR-181a-5p in non-small cell lung cancer. Oncol Res.
26:289–296. 2018. View Article : Google Scholar : PubMed/NCBI
|
15
|
Chen Q, Cai J, Wang Q, Wang Y, Liu M, Yang
J, Zhou J, Kang C, Li M and Jiang C: Long noncoding RNA NEAT1,
regulated by the EGFR pathway, contributes to glioblastoma
progression through the WNT/β-Catenin pathway by scaffolding EZH2.
Clin Cancer Res. 24:684–695. 2018. View Article : Google Scholar : PubMed/NCBI
|
16
|
An J, Lv W and Zhang Y: LncRNA NEAT1
contributes to paclitaxel resistance of ovarian cancer cells by
regulating ZEB1 expression via miR-194. Onco Targets Ther.
10:5377–5390. 2017. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhou Y, Yang C, Wang K, Liu X and Liu Q:
MicroRNA-33b inhibits the proliferation and migration of
osteosarcoma cells via targeting hypoxia-inducible factor-1α. Oncol
Res. 25:397–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
20
|
Wang Y, Xu C and Zhang X: MicroRNA-365
inhibits ovarian cancer progression by targeting Wnt5a. Am J Cancer
Res. 7:1096–1106. 2017.PubMed/NCBI
|
21
|
Zhu Y, Zhao H, Rao M and Xu S:
MicroRNA-365 inhibits proliferation, migration and invasion of
glioma by targeting PIK3R3. Oncol Rep. 37:2185–2192. 2017.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Pietruszewska W, Bojanowska-Poźniak K and
Kobos J: Matrix metalloproteinases MMP1, MMP2, MMP9 and their
tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: An
immunohistochemical study. Otolaryngol Pol. 70:32–43. 2016.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Wang P, Wu T, Zhou H, Jin Q, He G, Yu H,
Xuan L, Wang X, Tian L, Sun Y, et al: Long noncoding RNA NEAT1
promotes laryngeal squamous cell cancer through regulating
miR-107/CDK6 pathway. J Exp Clin Cancer Res. 35:222016. View Article : Google Scholar : PubMed/NCBI
|
25
|
Fu JW, Kong Y and Sun X: Long noncoding
RNA NEAT1 is an unfavorable prognostic factor and regulates
migration and invasion in gastric cancer. J Cancer Res Clin Oncol.
142:1571–1579. 2016. View Article : Google Scholar : PubMed/NCBI
|
26
|
Chen ZJ, Zhang Z, Xie BB and Zhang HY:
Clinical significance of up-regulated lncRNA NEAT1 in prognosis of
ovarian cancer. Eur Rev Med Pharmacol Sci. 20:3373–3377.
2016.PubMed/NCBI
|
27
|
Chen X, Kong J, Ma Z, Gao S and Feng X: Up
regulation of the long non-coding RNA NEAT1 promotes esophageal
squamous cell carcinoma cell progression and correlates with poor
prognosis. Am J Cancer Res. 5:2808–2815. 2015. View Article : Google Scholar : PubMed/NCBI
|
28
|
Ma Y, Liu L, Yan F, Wei W, Deng J and Sun
J: Enhanced expression of long non-coding RNA NEAT1 is associated
with the progression of gastric adenocarcinomas. World J Surg
Oncol. 14:412016. View Article : Google Scholar : PubMed/NCBI
|
29
|
Liu Z, Chang Q, Yang F, Liu B, Yao HW, Bai
ZG, Pu CS, Ma XM, Yang Y, Wang TT, et al: Long non-coding RNA NEAT1
overexpression is associated with unfavorable prognosis in patients
with hepatocellular carcinoma after hepatectomy: A Chinese
population-based study. Eur J Surg Oncol. 43:1697–1703. 2017.
View Article : Google Scholar : PubMed/NCBI
|